As a selective endogenous estrogen receptor (ER) agonist and liver-X-receptor (LXR) agonist, 27-HC may contribute to ER-positive breast cancer growth and metastasis by inducing several EMT genes and disrupting constitutive p53 signaling in an MDM2-dependent manner (92, 93). The gene discussed is TP53; the disease is breast carcinoma.